Glycostem to participate the CAR-TCR Digital Summit Europe during 16th to 18th Feb, 2021, with workshop with our CSO Jan Spanholtz: viveNK™ products (CAR-NK and TCR-NK) as autologous CAR-T alternatives and conference presentation by our CDO Volker Huppert: clinical scale closed manufacture system for allogeneic NK products on.
Glycostem to participate on BIO CEO & Investor Digital Conference during 16th to 18th Feb, 2021, one of the biggest biotech industry networking events in the U.S.
Glycostem to present at Virtual 8th Solebury Trout Private Company Showcase, with presentations and 1x1 calls on Friday, 29th January, 2021.
Glycostem to present at the business partnering event Advanced Therapy Showcase in Tokyo#1 on 21st January at 09.35 CET/17:35 GMT+9 with live streaming.
The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space.